APA (7th ed.) Citation

Kuo, Y., Zhu, Z., Jan, H., Hu, C., Ou, Y., Ou, C., . . . Wu, K. (2026). Alkaline phosphatase and platelet-to-lymphocyte ratio changes after initial radium-223 administration as predictors of overall survival in metastatic castration-resistant prostate cancer patients treated with radium-223: A retrospective cohort study. Urological Science, 37(3), 156. https://doi.org/10.1097/us9.0000000000000081

Chicago Style (17th ed.) Citation

Kuo, Yuh-Ren, Zhi-Jun Zhu, Hau-Chern Jan, Che-Yuan Hu, Yin-Chien Ou, Chien-Hui Ou, Yuh-Shyan Tsai, and Kuan-Yu Wu. "Alkaline Phosphatase and Platelet-to-lymphocyte Ratio Changes After Initial Radium-223 Administration as Predictors of Overall Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: A Retrospective Cohort Study." Urological Science 37, no. 3 (2026): 156. https://doi.org/10.1097/us9.0000000000000081.

MLA (9th ed.) Citation

Kuo, Yuh-Ren, et al. "Alkaline Phosphatase and Platelet-to-lymphocyte Ratio Changes After Initial Radium-223 Administration as Predictors of Overall Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: A Retrospective Cohort Study." Urological Science, vol. 37, no. 3, 2026, p. 156, https://doi.org/10.1097/us9.0000000000000081.